Canine Hip Dysplasia: Prevention, Management, and Welfare Implications

Hip dysplasia is among the most common hereditary conditions in dogs, causing chronic pain and mobility impairment that significantly affects quality of life.

Key Facts

Canine hip dysplasia (CHD) is a developmental condition where the hip joint does not form correctly, leading to joint laxity, abnormal wear, and eventually degenerative joint disease
Large breeds have the highest CHD rates: German Shepherds, Golden Retrievers, Labrador Retrievers, Rottweilers, and Great Danes are among the most commonly affected breeds, with prevalence rates of 15-30% or higher in some breed populations
CHD has a complex genetic basis — it is polygenic, meaning multiple genes contribute, and environmental factors including rapid growth, inappropriate exercise during development, and diet interact with genetic predisposition
The Orthopedic Foundation for Animals (OFA) and PennHIP evaluate hip joint quality in dogs — breeders who screen breeding stock and select away from poor hip scores can reduce CHD prevalence in their lines over generations
Signs of CHD in young dogs include: difficulty rising after rest, reluctance to climb stairs, bunny hopping gait at the run, and exercise intolerance — signs that owners often attribute to puppy clumsiness rather than pain
Treatment options range from medical management (pain relief, joint supplements, weight management, controlled exercise) to surgical interventions including triple pelvic osteotomy in young dogs and total hip replacement in mature dogs
Quality of life for dogs with CHD can be excellent with appropriate management — pain control through multimodal analgesia and weight management are the most impactful interventions for most affected dogs

Welfare Considerations

Canine hip dysplasia welfare begins with breeding decisions — the most effective welfare intervention is preventing CHD through breeding program management rather than treating it after diagnosis. Breeders who screen all breeding stock, require OFA Good or Excellent or PennHIP scores below breed median, and track hip health outcomes in offspring produce lines with dramatically lower CHD prevalence. The welfare cost of CHD is significant and progressive — a dog with moderate CHD living 12 years experiences potentially a decade of chronic joint pain that appropriate management can reduce but not eliminate. Early diagnosis through screening at 6-9 months allows intervention before severe degenerative change occurs. The welfare-positive management approach combines: appropriate pain management, weight management (excess weight dramatically worsens CHD symptoms), controlled low-impact exercise (swimming is ideal), and monitoring of progression to guide treatment escalation.

What You Can Do

If purchasing a large breed dog, verify that both parents have OFA Good or Excellent or above-average PennHIP scores for hip health
Learn to recognize early CHD signs in puppies — difficulty rising, exercise intolerance, and abnormal gait at 6-12 months warrant veterinary assessment
Manage weight carefully in large breed puppies — rapid weight gain worsens CHD outcomes and lifelong weight management is the most impactful non-pharmaceutical intervention
Discuss multimodal pain management with your veterinarian for diagnosed CHD — NSAIDs, joint supplements, gabapentin, and acupuncture all have evidence for combination approaches
Support canine health research including CHD genetic mapping that could eventually enable gene-based screening and more precise selection against CHD in breeding programs